Expertise in
12
conditions

Anja R. Schneider

Großhaderner Str. 2, 
Planegg, BY, DE 
Expertise in
12
conditions
Großhaderner Str. 2, 
Planegg, BY, DE 
OverviewLocationsClinical Research

Overview

Anja Schneider practices in Planegg, Germany. Ms. Schneider is highly rated in 12 conditions, according to our data. Her top areas of expertise are Dementia, Alzheimer's Disease, Alien Hand Syndrome, Primary Progressive Aphasia, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 220 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Großhaderner Str. 2, Planegg, BY 82152, Germany
Other Locations
Sigmund Freud Str. 25, Bonn, NW 53127, Germany
Von Siebold Str. 5, 37075 Göttingen, Hermann Rein Str. 3, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug, Other
Study Drug: IONIS MAPTRx
Study Phase: Phase 1
Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients
Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients
Enrollment Status: Unknown
Publish Date: January 27, 2020
Intervention Type: Drug
Study Drug: Simvastatin
Study Phase: Phase 4
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

220 Total Publications

An Unsupervised XAI Framework for Dementia Detection with Context Enrichment.
An Unsupervised XAI Framework for Dementia Detection with Context Enrichment.
Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Schneider's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile